Brian Udell, MD - Review of Recent Statistics for Patients Taking LDN in a Special Needs Pediatric Practice (2017 Conference) (LDN, low dose naltrexone)

Olga Cortez, MD - LDN Use in Women's Health II (2019 Conference) (LDN, low dose naltrexone)

Olga Cortez, MD - LDN Use in Women's Health I (2019 Conference) (LDN, low dose naltrexone)

Carrie Jones, ND, MPH - LDN and Cellular Hypothyroidism: Why you can't convert T4 into T3 (2019 Conference) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

LDN 2019 Conference - Sunday Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

Sarah Zielsdorf, MD, MS - Graves' Disease (2019 Conference) (LDN, low dose naltrexone)

Sarah Zielsdorf, MD discusses what Graves’ disease is, treatment strategies, related conditions and predisposing factors, and the work-up from a functional medicine standpoint

Pamela Smith, MD - LDN and Multiple Sclerosis (2019 Conference) (LDN, low dose naltrexone)

Michael Ruscio, DC - The Gut-Thyroid Connection, Profound but Under-Appreciated (2019 Conference) (LDN, low dose naltrexone)

Kent Holtorf, MD - Causes of Hashimoto's (2019 Conference) (LDN, low dose naltrexone)

Kent Holtorf, MD discusses Hasimoto’s thyroiditis at the LDN 2019 Conference. He discusses the mechanisms of thyroid dysfunction, causes and evaluation of Hashimoto’s thyroiditis, Hashimoto’s in obesity, and treatments of Hasimoto's
 

Harpal Bains, MBBS - The role LDN plays in the body's hormonal symphony: how a well-conducted orchestra enhances the efficacy of LDN (2019 Conference) (LDN, low dose naltrexone)